325
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Neuropsychiatric Symptoms Assessment: Cross-cultural Adaptation and Validation of the Portuguese Abe’s BPSD Score (ABS)

ORCID Icon, , , , &

References

  • Abe, K., Yamashita, T., Hishikawa, N., Ohta, Y., Deguchi, K., Sato, K., … Wakutani, Y. (2015). A new simple score (ABS) for assessing behavioral and psychological symptoms of dementia. Journal of the Neurological Sciences, 350(1–2), 14–17.
  • Alvares Pereira, G., Sousa, I., & Nunes, M. V. S. (2020). Cultural adaptation of Cognitive Stimulation Therapy (CST) for Portuguese people with dementia. Clinical Gerontologist, 1–12. https://doi.org/https://doi.org/10.1080/07317115.2020.1821857
  • Bajpai, S., Upadhyay, A., Sati, H., Pandey, R., Chaterjee, P., & Dey, A. (2020). Hindi version of Addenbrooke’s cognitive examination III: Distinguishing cognitive impairment among older Indians at the lower cut-offs. Clinical Interventions in Aging, 15, 329.
  • Boada, M., Cejudo, J., Tarraga, L., Lopez, O., & Kaufer, D. (2002). Neuropsychiatric inventory questionnaire (NPI-Q): Spanish validation of an abridged form of the neuropsychiatric inventory (NPI). Neurología (Barcelona, Spain), 17(6), 317–323.
  • Braun, A., Trivedi, D. P., Dickinson, A., Hamilton, L., Goodman, C., Gage, H., … Manthorpe, J. (2018). Managing behavioural and psychological symptoms in community dwelling older people with dementia: 2. A systematic review of qualitative studies. Dementia, 18(7-9), 2950–2970.
  • Burhanullah, M. H., Tschanz, J. T., Peters, M. E., Leoutsakos, J.-M., Matyi, J., Lyketsos, C. G., … Rosenberg, P. B. (2020). Neuropsychiatric symptoms as risk factors for cognitive decline in clinically normal older adults: The cache county study. The American Journal of Geriatric Psychiatry, 28(1), 64–71.
  • Burley, C. V., Livingston, G., Knapp, M. R., Wimo, A., Norman, R., & Brodaty, H. (2020). Time to invest in prevention and better care of behaviors and psychological symptoms associated with dementia. International Psychogeriatrics, 32(5), 567–572.
  • Camozzato, A. L., Godinho, C., Kochhann, R., Massochini, G., & Chaves, M. L. (2015). Validity of the Brazilian version of the neuropsychiatric inventory questionnaire (NPI-Q). Arquivos De Neuro-psiquiatria, 73(1), 41–45.
  • Chow, T., Liu, C., Fuh, J., Leung, V., Tai, C., Chen, L. W., … Chen, Q. (2002). Neuropsychiatric symptoms of Alzheimer’s disease differ in Chinese and American patients. International Journal of Geriatric Psychiatry, 17(1), 22–28.
  • Cicchetti, D. V. (1994). Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychological Assessment, 6(4), 284.
  • Cooper, C., Sommerlad, A., Lyketsos, C. G., & Livingston, G. (2015). Modifiable predictors of dementia in mild cognitive impairment: A systematic review and meta-analysis. American Journal of Psychiatry, 172(4), 323–334.
  • Cummings, J. (2020a). The neuropsychiatric inventory: Development and applications. Journal of Geriatric Psychiatry and Neurology, 33(2), 73–84.
  • Cummings, J. (2020b). The role of neuropsychiatric symptoms in research diagnostic criteria for neurodegenerative diseases. The American Journal of Geriatric Psychiatry. https://www.ajgponline.org/article/S1064-7481(20)30419-X/fulltext
  • Cummings, J., Pinto, L. C., Cruz, M., Fischer, C. E., Gerritsen, D. L., Grossberg, G. T., … Koopmans, R. (2020). Criteria for psychosis in major and mild neurocognitive disorders: international psychogeriatric association (IPA) consensus clinical and research definition. The American Journal of Geriatric Psychiatry, 28(12), 1256–1269.
  • Cummings, J. L. (1997). Theories behind existing scales for rating behavior in dementia. International Psychogeriatrics, 8(S3), 293–300.
  • Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44(12), 2308–2308.
  • Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994). The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology, 44(12), 2308.
  • De Medeiros, K., Robert, P., Gauthier, S., Stella, F., Politis, A., Leoutsakos, J., … Porsteinsson, A. (2010). The neuropsychiatric inventory-clinician rating scale (NPI-C): Reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. International Psychogeriatrics, 22(6), 984–994.
  • Ferreira, A. R., Martins, S., Ribeiro, O., & Fernandes, L. (2015). Validity and reliability of the european portuguese version of neuropsychiatric inventory in an institutionalized sample. Journal of Clinical Medicine Research, 7(1), 21. doi:https://doi.org/10.14740/jocmr1959w
  • Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198. https://www.ncbi.nlm.nih.gov/pubmed/1202204
  • Fuh, J.-L., Lam, L., Hirono, N., Senanarong, V., & Cummings, J. L. (2006). Neuropsychiatric inventory workshop: Behavioral and psychologic symptoms of dementia in Asia. Alzheimer Disease and Associated Disorders, 20(4), 314–317.
  • Fuh, J.-L., Liu, C.-K., Mega, M. S., Wang, S.-J., & Cummings, J. L. (2001). Behavioral disorders and caregivers’ reaction in Taiwanese patients with Alzheimer’s disease. International Psychogeriatrics, 13(1), 121–128.
  • Fukui, Y., Yamashita, T., Hishikawa, N., Kurata, T., Sato, K., Omote, Y., … Hatanaka, N. (2015). Computerized touch-panel screening tests for detecting mild cognitive impairment and Alzheimer’s disease. Internal Medicine, 54(8), 895–902.
  • Gallagher, D., Fischer, C. E., & Iaboni, A. (2017). Neuropsychiatric symptoms in mild cognitive impairment: An update on prevalence, mechanisms, and clinical significance. The Canadian Journal of Psychiatry, 62(3), 161–169.
  • Gauthier, S., Cummings, J., Ballard, C., Brodaty, H., Grossberg, G., Robert, P., & Lyketsos, C. (2010). Management of behavioral problems in Alzheimer’s disease. International Psychogeriatrics, 22(3), 346–372.
  • Geda, Y. E., Roberts, R. O., Knopman, D. S., Petersen, R. C., Christianson, T. J., Pankratz, V. S., … Tangalos, E. G. (2008). Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: Population-based study. Archives of General Psychiatry, 65(10), 1193–1198. doi:https://doi.org/10.1001/archpsyc.65.10.1193
  • Gitlin, L. N., Marx, K. A., Stanley, I. H., Hansen, B. R., & Van Haitsma, K. S. (2014). Assessing neuropsychiatric symptoms in people with dementia: A systematic review of measures. International Psychogeriatrics, 26(11), 1805–1848.
  • Ikeda, M., Shigenobu, K., Fukuhara, R., Hokoishi, K., Nebu, A., Maki, N., … Tanabe, H. (2003). Delusions of Japanese patients with Alzheimer’s disease. International Journal of Geriatric Psychiatry, 18(6), 527–532.
  • Ismail, Z., & Mortby, M. E. (2017). Cognitive and neuropsychiatric screening tests in older adults. Mental Health and Illness of the Elderly, 343–368. https://doi.org/https://doi.org/10.1007/978-981-10-2414-6_16
  • Ismail, Z., Smith, E. E., Geda, Y., Sultzer, D., Brodaty, H., Smith, G., … Lyketsos, C. G. (2016). Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimer’s & Dementia, 12(2), 195–202.
  • Jeon, Y.-H., Sansoni, J., Low, L.-F., Chenoweth, L., Zapart, S., Sansoni, E., & Marosszeky, N. (2011). Recommended measures for the assessment of behavioral disturbances associated with dementia. The American Journal of Geriatric Psychiatry, 19(5), 403–415.
  • Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015). Assessment and management of behavioral and psychological symptoms of dementia. Bmj, 350(7), h369. doi:https://doi.org/10.1136/bmj.h369
  • Kales, H. C., Gitlin, L. N., Lyketsos, C. G., Assessment, D. E. P. O. T., & Dementia, M. O. T. N. S. O. (2014). Management of neuropsychiatric symptoms of dementia in clinical settings: Recommendations from a multidisciplinary expert panel. Journal of the American Geriatrics Society, 62(4), 762–769. doi:https://doi.org/10.1111/jgs.12730
  • Kaufer, D. I., Cummings, J. L., Christine, D., Bray, T., Castellon, S., Masterman, D., … DeKosky, S. T. (1998). Assessing the impact of neuropsychiatric symptoms in Alzheimer’s disease: The neuropsychiatric inventory caregiver distress scale. Journal of the American Geriatrics Society, 46(2), 210–215.
  • Kaufer, D. I., Cummings, J. L., Ketchel, P., Smith, V., MacMillan, A., Shelley, T., … DeKosky, S. T. (2000). Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. The Journal of Neuropsychiatry and Clinical Neurosciences, 12(2), 233–239.
  • Kim, H.-J., Choi, K. H., Kim, S. H., Cummings, J. L., & Yang, D.-W. (2016). Validation study of the Korean version of the brief clinical form of the neuropsychiatric inventory. Dementia and Geriatric Cognitive Disorders Extra, 6(2), 214–221.
  • Lai, C. K. (2014). The merits and problems of neuropsychiatric inventory as an assessment tool in people with dementia and other neurological disorders. Clinical Interventions in Aging, 9, 1051.
  • Lanctôt, K. L., Agüera-Ortiz, L., Brodaty, H., Francis, P. T., Geda, Y. E., Ismail, Z., … Padala, P. R. (2017). Apathy associated with neurocognitive disorders: Recent progress and future directions. Alzheimer’s & Dementia, 13(1), 84–100.
  • Leung, V. P., Lam, L. C., Chiu, H. F., Cummings, J. L., & Chen, Q. (2001). Validation study of the Chinese version of the neuropsychiatric inventory (CNPI). International Journal of Geriatric Psychiatry, 16(8), 789–793.
  • Lyketsos, C. G., Carrillo, M. C., Ryan, J. M., Khachaturian, A. S., Trzepacz, P., Amatniek, J., … Miller, D. S. (2011). Neuropsychiatric symptoms in Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 7(5), 532–539.
  • Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. Jama, 288(12), 1475–1483. https://www.ncbi.nlm.nih.gov/pubmed/12243634
  • Matsuzono, K., Hishikawa, N., Yamashita, T., Ohta, Y., Sato, K., Kono, S., … Abe, K. (2015). Comprehensive clinical evaluations of frontotemporal dementia contrasting to Alzheimer’s disease (oFTD study). Journal of Alzheimer’s Disease, 48(1), 279–286.
  • Matsuzono, K., Sato, K., Kono, S., Hishikawa, N., Ohta, Y., Yamashita, T., … Abe, K. (2015). Clinical benefits of rivastigmine in the real world dementia clinics of the Okayama Rivastigmine study (ORS). Journal of Alzheimer’s Disease, 48(3), 757–763.
  • Matsuzono, K., Yamashita, T., Ohta, Y., Hishikawa, N., Koike, M., Sato, K., … Abe, K. (2015). Clinical benefits of memantine treatment for Alzheimer’s disease in the Okayama memantine study II (OMS II). Journal of Alzheimer’s Disease, 47(2), 487–493.
  • Mokkink, L. B., Prinsen, C. A., Patrick, D. L., Alonso, J., Bouter, L. M., De Vet, H., & Terwee, C. B. (2019). COSMIN study design checklist for patient-reported outcome measurement instruments. Department of Epidemiology and Biostatistics.
  • Morgado, J., Rocha, C. S., Maruta, C., Guerreiro, M., & Martins, I. P. (2009). Novos valores normativos do mini-mental state examination. Sinapse, 9(2), 10–16.
  • Mortby, M. E., Lyketsos, C. G., Geda, Y. E., & Ismail, Z. (2018). Special Issue on mild behavioral impairment and non-cognitive prodromes to dementia. International Psychogeriatrics, 30(2), 167–169.
  • Nakano, Y., Matsuzono, K., Yamashita, T., Ohta, Y., Hishikawa, N., Sato, K., … Abe, K. (2015). Long-term efficacy of galantamine in Alzheimer’s disease: The Okayama Galantamine Study (OGS). Journal of Alzheimer’s Disease, 47(3), 609–617.
  • Nunnally, J. C. (1994). Psychometric theory, 3rd Ed. New York: McGraw-Hill Education.
  • Ohta, Y., Darwish, M., Hishikawa, N., Yamashita, T., Sato, K., Takemoto, M., & Abe, K. (2017). Therapeutic effects of drug switching between acetylcholinesterase inhibitors in patients with Alzheimer’s disease. Geriatrics & Gerontology International, 17(11), 1843–1848.
  • Ohta, Y., Nomura, E., Hatanaka, N., Osakada, Y., Matsumoto, N., Sasaki, R., … Hishikawa, N. (2019). Female dominant association of sarcopenia and physical frailty in mild cognitive impairment and Alzheimer’s disease. Journal of Clinical Neuroscience, 70, 96–101.
  • Ohta, Y., Sato, K., Takemoto, M., Takahashi, Y., Morihara, R., Nakano, Y., … Yamashita, T. (2017). Behavioral and affective features of amyotrophic lateral sclerosis patients. Journal of the Neurological Sciences, 381, 119–125.
  • Pang, F., Chow, T., Cummings, J., Leung, V., Chiu, H., Lam, L., … Wang, S. (2002). Effect of neuropsychiatric symptoms of Alzheimer’s disease on Chinese and American caregivers. International Journal of Geriatric Psychiatry, 17(1), 29–34.
  • Perrault, A., Oremus, M., Demers, L., Vida, S., & Wolfson, C. (2000). Review of outcome measurement instruments in Alzheimer’s disease drug trials: Psychometric properties of behavior and mood scales. Journal of Geriatric Psychiatry and Neurology, 13(4), 181–196.
  • Peters, M., Rosenberg, P. B., Steinberg, M., Norton, M., Welsh-Bohmer, K., Hayden, K., … Investigators, C. C. (2013). Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: The cache county study. The American Journal of Geriatric Psychiatry, 21(11), 1116–1124.
  • Prinsen, C. A., Mokkink, L. B., Bouter, L. M., Alonso, J., Patrick, D. L., De Vet, H. C., & Terwee, C. B. (2018). COSMIN guideline for systematic reviews of patient-reported outcome measures. Quality of Life Research, 27(5), 1147–1157.
  • Saari, T., Koivisto, A., Hintsa, T., Hänninen, T., & Hallikainen, I. (2020). Psychometric properties of the neuropsychiatric inventory: A review. Journal of Alzheimer’s Disease, Preprint, 1–15.
  • Santana, I., Cunha, C., Duro, D., Santiago, B., Simões, M. R., Ferreira, A. R., … Fernandes, L. (2015). Inventário neuropsiquiátrico (NPI) [Neuropsychiatric inventory (NPI)]. In M. R. Simões, I. Santana, & GEECD (Eds.), Escalas e Testes na Demência (pp. 120–127). Lisboa: Novartis.
  • Sayegh, P., & Knight, B. G. (2013). Cross-cultural differences in dementia: The sociocultural health belief model. International Psychogeriatrics, 25(4), 517–530.
  • Shah, A. (2000). What are the necessary characteristics of a behavioral and psychological symptoms of dementia rating scale? International Psychogeriatrics, 12(S1), 205.
  • Shah, A., Dalvi, M., & Thompson, T. (2005). Behavioural and psychological signs and symptoms of dementia across cultures: Current status and the future. International Journal of Geriatric Psychiatry: A Journal of the Psychiatry of Late Life and Allied Sciences, 20(12), 1187–1195.
  • Sink, K. M., Covinsky, K. E., Barnes, D. E., Newcomer, R. J., & Yaffe, K. (2006). Caregiver characteristics are associated with neuropsychiatric symptoms of dementia. Journal of the American Geriatrics Society, 54(5), 796–803.
  • Stevens, J. P. (2012). Applied multivariate statistics for the social sciences. New York: Routledge.
  • Takemoto, M., Sato, K., Hatanaka, N., Yamashita, T., Ohta, Y., Hishikawa, N., & Abe, K. (2016). Different clinical and neuroimaging characteristics in early stage Parkinson’s disease with dementia and dementia with Lewy bodies. Journal of Alzheimer’s Disease, 52(1), 205–211.
  • Tokuchi, R., Hishikawa, N., Matsuzono, K., Takao, Y., Wakutani, Y., Sato, K., … Yamashita, T. (2016). Cognitive and affective benefits of combination therapy with galantamine plus cognitive rehabilitation for Alzheimer’s disease. Geriatrics & Gerontology International, 16(4), 440–445.
  • Tokuchi, R., Hishikawa, N., Sato, K., Hatanaka, N., Fukui, Y., Takemoto, M., … Abe, K. (2016a). Age-dependent cognitive and affective differences in Alzheimer’s and Parkinson’s diseases in relation to MRI findings. Journal of the Neurological Sciences, 365, 3–8.
  • Tokuchi, R., Hishikawa, N., Sato, K., Hatanaka, N., Fukui, Y., Takemoto, M., … Abe, K. (2016b). Differences between the behavioral and psychological symptoms of Alzheimer’s disease and Parkinson’s disease. Journal of the Neurological Sciences, 369, 278–282.
  • Tsunoda, K., Yamashita, T., Osakada, Y., Sasaki, R., Tadokoro, K., Matsumoto, N., … Takahashi, Y., Subjects, C. N., & Impairment, M. C. (2020). Early emergence of neuropsychiatric symptoms in Cognitively Normal Subjects and Mild Cognitive Impairment. Journal of Alzheimer’s Disease, Preprint, 1–7.
  • van der Linde, R. M., Stephan, B. C., Dening, T., & Brayne, C. (2014). Instruments to measure behavioural and psychological symptoms of dementia. International Journal of Methods in Psychiatric Research, 23(1), 69–98.
  • Vik‐Mo, A. O., Giil, L. M., Ballard, C., & Aarsland, D. (2018). Course of neuropsychiatric symptoms in dementia: 5‐year longitudinal study. International Journal of Geriatric Psychiatry, 33(10), 1361–1369.
  • Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., & Erikson, P. (2005). ISPOR task force for translation and cultural adaptation. principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 8(2), 94–104.
  • Woods, D. L., & Buckwalter, K. 2018. Taking another look: Thoughts on behavioral symptoms in dementia and their measurement. In Healthcare.
  • Woolley, J. D., Khan, B. K., Murthy, N. K., Miller, B. L., & Rankin, K. P. (2011). The diagnostic challenge of psychiatric symptoms in neurodegenerative disease; rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. The Journal of Clinical Psychiatry, 72(2), 126.
  • Wu, H. Z. Y., Low, L.-F., Xiao, S., & Brodaty, H. (2009). A pilot study of differences in behavioral and psychological symptoms of dementia in nursing home residents in Sydney and Shanghai. International Psychogeriatrics, 21(3), 476–484.
  • Zhao, Q.-F., Tan, L., Wang, H.-F., Jiang, T., Tan, M.-S., Tan, L., … Lai, T.-J. (2016). The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: Systematic review and meta-analysis. Journal of Affective Disorders, 190, 264–271.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.